Clinical effectiveness of branded versus generic piperacillin-tazobactam for treating severe community-acquired pneumonia

• Автори: Cheng-Yi Wang (Автор), Chia-Hung Chen (Автор), Chih-Yen Tu (Автор), Wei-Chih Chen (Автор), Li-Kuo Kuo (Автор), Yao-Tung Wang (Автор), Pin-Kuei Fu (Автор), Shih-Chi Ku (Автор), Wen-Feng Fang (Автор), Chin-Ming Chen (Автор), Chih-Cheng Lai (Автор)
• Формат: Книга
• Опубліковано: Elsevier, 2022-09-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Purpose: To compare the clinical effectiveness of branded versus generic piperacillin-tazobactam for treating severe community-acquired pneumonia (CAP). Patients and methods: We identified patients with severe CAP who received piperacillin-tazobactam based on a nine-center registry database. Further...